World news, news around town, tech update 3
Ad
Tuesday, 30 May 2017
Gilead's HIV combination therapy succeeds in four late-stage studies
(Reuters) - Gilead Sciences Inc said on Tuesday its combination treatment for HIV met the main goal in four late-stage studies, paving the way for regulatory submissions.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment